Status:
TERMINATED
Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Laboratoires Takeda
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
35-75 years
Phase:
NA
Brief Summary
In type 2 diabetic patients with poor glycemic control despite maximum "classic" oral treatment, bed time insulin therapy may lead to a parallel increase in abdominal visceral and subcutaneous fat, wh...
Detailed Description
In type 2 diabetic patients with poor glycemic control despite maximum "classic" oral treatment, bed time insulin therapy may lead to a parallel increase in abdominal visceral and subcutaneous fat, wh...
Eligibility Criteria
Inclusion
- Type 2 diabetes
- BMI= 26kg/m2
- Maximal treatment with metformin and sulfonylurea
- HbA1c between 7.5 and 9.5%
Exclusion
- Anterior treatment with glitazones
- Anterior treatment with insulin
- Known heart failure
- Hepatopathy
- Renal filtration less than 60ml/min, Hb\<10g/dl
- Corticoids treatment
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00159211
Start Date
May 1 2005
End Date
May 1 2007
Last Update
November 8 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sce de Diabétologie, hôpital de la Pitié-salpêtrière, 83bld de l'hôpital
Paris, France, 75013